Affordable Access

Assessment of the role of thrombin activatable fibrinolysis inhibitor in retinal vein occlusion.

Authors
  • Gumus, Koray
  • Kadayifcilar, Sibel
  • Eldem, Bora
  • Ozcebe, Osman
Type
Published Article
Journal
Retina
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Jun 01, 2007
Volume
27
Issue
5
Pages
578–583
Identifiers
PMID: 17558319
Source
Medline
License
Unknown

Abstract

On the basis of these data, TAFI activity was not found to be a new risk factor for either type of RVO. However, further larger studies may better identify the exact role of TAFI in the pathogenesis of RVO.

Report this publication

Statistics

Seen <100 times